Sakar Healthcare Stock Surges on EU Approval

  Published 9 months ago

Sakar Healthcare shares rise 5% after EU approval for cancer drug, with more product approvals expected soon.

  • India’s Sakar Healthcare gains 5% as EU approves colorectal cancer injection.
  • The company expects EU approvals for oral solids and injections in the next months.
  • Trading volume triples to 115k shares; stock up 16% year to date.

You might like these

L&T Plans Green Hydrogen Plant

Airtel’s AI Spam Defense Wins I4C Praise

ACC Q1 Profit Rises 5% on Volume Boost

India's FY25 Finances: Key Highlights

India Expands STRIPS for State Bonds

India's Diesel Shift: Asia Gains, Europe Feels Pinch

NTPC Expands Capacity with New 660 MW Unit

News that matters the most ⚡